Amgen Bone Drug Shows Promise
 

Patients taking hormone blockers to fight breast cancer showed improvements in bone density when given shots of an experimental Amgen Inc. bone drug, researchers said

To read full article:
http://online.wsj.com/article/SB1197...googlenews_wsj

wonder what the drug is?

Denosumab

From Wikipedia, the free encyclopedia


Jump to: navigation, search
<!-- start content -->Denosumab (formerly known as AMG 162) is a human monoclonal antibody which is used to treat osteoporosis. Denosumab is designed to target RANK Ligand, a protein that acts as the primary signal to promote bone removal. In many bone loss conditions, RANK Ligand overwhelms the body's natural defense against bone destruction.